The Use of Specific Monoclonal Antibodies to Target Immunogenic Tumor Membrane Proteins in Patients with Recurrent Pancreatic and Colon Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|9|1|52-56

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.9, Iss.1, 2012-01, pp. : 52-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radioimmunotherapy of Cancer Using Monoclonal Antibodies to Target Radiotherapy

By  

Current Pharmaceutical Design, Vol. 6, Iss. 14, 2000-09 ,pp. : 1399-1418

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnostic and Therapeutic Use of Membrane Proteins in Cancer Cells

By  

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 176-190

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tumor Monoclonal Antibodies in Conjunction with &bgr;-Glucans: A Novel Anti- Cancer Immunotherapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4298-4305

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-05 ,pp. : 134-143

Bentham Science Publishers

Access to resources Recommend Favorite

Genetically Engineered Monoclonal Antibodies for Direct Anti-Neoplastic Treatment and Cancer Cell Specific Delivery of Chemotherapeutic Agents

By  

Current Pharmaceutical Design, Vol. 6, Iss. 3, 2000-02 ,pp. : 261-276

Bentham Science Publishers

Access to resources Recommend Favorite